173 related articles for article (PubMed ID: 20493848)
1. Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.
Grosso NL; Bua J; Perrone AE; Gonzalez MN; Bustos PL; Postan M; Fichera LE
Exp Parasitol; 2010 Oct; 126(2):239-44. PubMed ID: 20493848
[TBL] [Abstract][Full Text] [Related]
2. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE
Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: Biological characterization of lineages I and II supports the predominance of lineage I in Colombia.
Mejía-Jaramillo AM; Peña VH; Triana-Chávez O
Exp Parasitol; 2009 Jan; 121(1):83-91. PubMed ID: 18950627
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole.
Martínez I; Nogueda B; Martínez-Hernández F; Espinoza B
Vector Borne Zoonotic Dis; 2013 Mar; 13(3):181-7. PubMed ID: 23421890
[TBL] [Abstract][Full Text] [Related]
5. [Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia].
Mejía-Jaramillo AM; Fernández GJ; Montilla M; Nicholls RS; Triana-Chávez O
Biomedica; 2012 Jun; 32(2):196-205. PubMed ID: 23242293
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with benznidazole and allopurinol in mice infected with a virulent Trypanosoma cruzi isolate from Nicaragua.
Grosso NL; Alarcon ML; Bua J; Laucella SA; Riarte A; Fichera LE
Parasitology; 2013 Sep; 140(10):1225-33. PubMed ID: 23507037
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil.
Toledo MJ; Guilherme AL; da Silva JC; de Gasperi MV; Mendes AP; Gomes ML; de Araújo SM
Rev Inst Med Trop Sao Paulo; 1997; 39(5):283-90. PubMed ID: 9661307
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
14. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
[TBL] [Abstract][Full Text] [Related]
15. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
18. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
20. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
